Delivery Order SPE2DR25D3010-SPE2DR26F87ZB
- Not listed
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a $1,682.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Epidiolex 100 mg/ml solution in a 100 ml pack. This non-set-aside competitive award is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is a cannabidiol-based pharmaceutical used primarily for seizure management, reflecting the federal government's medical supply procurement...
- The Defense Logistics Agency awarded a $8,412.50 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $1,349.88 and an ultimate completion date of December 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with a ceiling value of $1,280.92 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, valued at $1,280.92. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, valued at $10,095.00 under a firm fixed price arrangement. The delivery order, which is non-set-aside and competitively awarded, has an ultimate completion date of May 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F87ZBDelivery Order
The Defense Logistics Agency awarded a $1,349.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs. This is a firm fixed-price, non-set-aside contract with a completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol-based medication primarily used for the treatment of seizure disorders, particularly in pediatric populations with specific epilepsy syndromes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's broad contract portfolio with the Defense Logistics Agency demonstrates its capability to supply diverse pharmaceutical products, including specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 11/14/25 |